Inherited bone marrow failure syndromes: considerations pre- and posttransplant
- 8 December 2017
- journal article
- research article
- Published by American Society of Hematology in Hematology-American Society Hematology Education Program
- Vol. 2017 (1) , 88-95
Abstract
Patients with inherited bone marrow failure syndromes are usually identified when they develop hematologic complications such as severe bone marrow failure, myelodysplastic syndrome, or acute myeloid leukemia. They often have specific birth defects or other physical abnormalities that suggest a syndrome, and sequencing of specific genes or next-generation sequencing can determine or confirm the particular syndrome. The 4 most frequent syndromes are Fanconi anemia, dyskeratosis congenita, Diamond Blackfan anemia, and Shwachman Diamond syndrome. This review discusses the major complications that develop as the patients with these syndromes age, as well as additional late effects following hematopoietic stem cell transplantation. The most common complications are iron overload in transfused patients and syndrome-specific malignancies in untransplanted patients, which may occur earlier and with higher risks in those who have received transplants.Keywords
This publication has 44 references indexed in Scilit:
- Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell TransplantationNew England Journal of Medicine, 2017
- Hematopoietic cell transplantation in Fanconi anemia: current evidence, challenges and recommendationsExpert Review of Hematology, 2016
- Late effects in patients with Fanconi anemia following allogeneic hematopoietic stem cell transplantation from alternative donorsBone Marrow Transplantation, 2016
- Squamous cell carcinomas in patients with Fanconi anemia and dyskeratosis congenita: A search for human papillomavirusInternational Journal of Cancer, 2013
- Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort studyBritish Journal of Haematology, 2010
- Pathophysiology and management of inherited bone marrow failure syndromesBlood Reviews, 2010
- Cancer in dyskeratosis congenitaBlood, 2009
- Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNAThe Lancet, 2003
- Serum pancreatic enzymes define the pancreatic phenotype in patients with Shwachman-Diamond syndromeThe Journal of Pediatrics, 2002
- Solid Cancers after Bone Marrow TransplantationNew England Journal of Medicine, 1997